GlassScriptPhysician profile
John Frank Van Deman
NPI 1043659584
$1,927.87
in general payments reported to CMS, 2019-2025
26 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $189 · 2021: $300 · 2022: $402 · 2023: $316 · 2024: $91.97 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587 · Education: $17.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $586.83 |
| Education | $17.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $791.75 | 2019-2023 | Liletta, Orilissa, Lo Loestrin Fe |
| Pfizer INC. | $169.63 | 2020-2024 | |
| Coopersurgical, INC. | $132.44 | 2019-2023 | Advincula Delineator Uterine Manipulator |
| Baxter Healthcare | $108.95 | 2025 | Perclot |
| Astellas Pharma US INC | $105.70 | 2023-2025 | Veozah |
| Daiichi Sankyo INC. | $67.39 | 2019-2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $66.18 | 2021-2023 | |
| Exeltis, USA INC. | $65.52 | 2021-2024 | Slynd |
| Exact Sciences Corporation | $46.35 | 2023 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $41.12 | 2023-2024 | Myfembree |
| Amag Pharmaceuticals, INC. | $34.42 | 2019-2020 | |
| Minerva Surgical, INC | $34.02 | 2019 | |
| Myovant Sciences INC. | $33.29 | 2022 | |
| Duchesnay USA Incorporated | $30.74 | 2019 | |
| Ethicon US, LLC | $26.69 | 2023 | Echelon; Endopath |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $21.49 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $20.82 | 2022 | |
| Mylan Pharmaceuticals INC. | $19.71 | 2022 | |
| Lupin INC. | $17.51 | 2019 | |
| Scynexis, INC. | $16.31 | 2022 | |
| Hologic Sales and Service, LLC | $15.68 | 2024 | Myosure Tissue Removal Device |
| Therapeuticsmd, INC. | $15.19 | 2020 | |
| Millicent US INC | $13.14 | 2019 | |
| Olympus America INC. | $12.96 | 2023 | |
| Agile Therapeutics, INC. | $11.28 | 2021 | |
| Aspira Women'S Health INC | $9.59 | 2023 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Van Deman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.